10:35 a.m. - 11:35 a.m.
The Role of Venture Capital in Healthcare: Improved Returns, Reduced Risk and Better Care
In the first three quarters of 2018, venture capital involvement in health care has further accelerated. The third quarter saw an estimated $4.5 billion in digital health funding—the most of any quarter on record.
The growth of venture capital and venture capital -backed startups deserves the attention of healthcare leaders because advancements in medicine are no longer exclusively born from providers within the delivery system and increasingly from innovators outside of it.
While venture capital -backed startups in digital health offer opportunities to affect the cost and quality of care, they often pose potential risks to patient care. An analytic framework for understanding the role of venture capital in medicine is still lacking.
Gain insight into:
The impact of startups in health care and the benefits and drawbacks
Establishing an evidence base that supported by a culture of change and innovation
Trends in M&A and VC Investment in Healthcare
Building successful business models centered on lowering spending in a revenue-maximizing system
Senior Managing Director
Kaiser Permanente Ventures
Sam Brasch leads the program at Kaiser Permanente Ventures as the group’s senior managing director. He returned to KPV in 2016 to lead the corporate venture fund’s activities after serving as a venture partner at New Leaf Venture Partners and as a senior advisor to Health Catalyst. Sam’s health care industry experience spans more than two decades. During his tenure at Kaiser Permanente Ventures from 2011 to 2014, Sam led the group’s investments in iRhythm Technologies, Health Catalyst, Nordic Consulting, and multiple other companies. Earlier in his career, Sam was a vice president with Frazier Healthcare Partners, a Seattle-based venture capital firm, and a senior manager with Medtronic, Inc. Sam has also worked in multiple healthcare technology start-ups. He began his career as a management consultant with APM/CSC Healthcare.
Senior Managing Director
Matt Hermann actively leads Ascension Venture's overall investing efforts. Matt has held board member or observer roles at several AV portfolio companies. Before joining AV in 2001, he served as vice president with Atlantic Medical, a New York-based venture capital management company focused on early- to mid-stage healthcare services and information technology investments. Prior to that, Matt served in financial management roles at two publicly traded healthcare companies, Nutrition 21, Inc. and Regeneron Pharmaceuticals, Inc., and worked at J.P. Morgan Chase & Co. and PricewaterhouseCoopers in New York City.
James Rogers III
Mayo Clinic Department of Business Development
James Rogers III serves as chair of Mayo Clinic’s Department of Business Development. This department is the front door for partners to work with Mayo Clinic. The department is responsible for Mayo Clinic’s full spectrum of business development activities, including technology development, startups and licensing, partnering, venture investing and acquisitions. The department reports to Mayo Clinic’s chief executive officer and chief administrative officer. Mr. Rogers is secretary of the Business Development Committee for the Mayo Clinic Board of Trustees, and he serves on the Mayo Clinic Administrative Team, Mayo Clinic Administrative Team Executive Committee, and the investment committee of Mayo’s $100 million Venture and Growth Fund.
Anne Wellington is the managing director of the Cedars-Sinai Accelerator. She leads the accelerator program, identifying the most promising early-stage healthtech and digital health companies, and providing expertise and guidance as these companies collaborate with Cedars-Sinai to rapidly iterate and scale innovative technology solutions. Prior to her current role, she supported the Accelerator program as Entrepreneur-in-Residence. Previously, Anne was Chief Product Officer and a founding team member at Stanson Health, where she developed an EMR-integrated, patient-specific clinical decision support and analytics product, named by KLAS as the #1 solution for clinical process improvement and recently acquired by Premier, Inc.